Analysis Metabolite Name Measured Value Units Construct
Reversed phase NEGATIVE ION MODELEUCINE (CAS# 328-39-2); (M-H)-20866Peak areaNoxa knockdown
Reversed phase NEGATIVE ION MODELEUCINE (CAS# 328-39-2); (M-H)-22555Peak areaNoxa knockdown
Reversed phase NEGATIVE ION MODELEUCINE (CAS# 328-39-2); (M-H)-23791Peak areaNoxa knockdown
Reversed phase NEGATIVE ION MODELEUCINE (CAS# 328-39-2); (M-H)-26342Peak areaControl lentivirus
Reversed phase NEGATIVE ION MODELEUCINE (CAS# 328-39-2); (M-H)-28057Peak areaControl lentivirus
Reversed phase NEGATIVE ION MODELEUCINE (CAS# 328-39-2); (M-H)-31149Peak areaControl lentivirus
Reversed phase POSITIVE ION MODELEUCINE (CAS# 328-39-2); (M+H)+13400000Peak areaControl lentivirus
Reversed phase POSITIVE ION MODELEUCINE (CAS# 328-39-2); (M+H)+14600000Peak areaControl lentivirus
Reversed phase POSITIVE ION MODELEUCINE (CAS# 328-39-2); (M+H)+14800000Peak areaNoxa knockdown
Reversed phase POSITIVE ION MODELEUCINE (CAS# 328-39-2); (M+H)+14900000Peak areaNoxa knockdown
Reversed phase POSITIVE ION MODELEUCINE (CAS# 328-39-2); (M+H)+15500000Peak areaControl lentivirus
Reversed phase POSITIVE ION MODELEUCINE (CAS# 328-39-2); (M+NA)+82937Peak areaNoxa knockdown
Reversed phase POSITIVE ION MODELEUCINE (CAS# 328-39-2); (M+NA)+85641Peak areaNoxa knockdown
Reversed phase POSITIVE ION MODELEUCINE (CAS# 328-39-2); (M+NA)+88087Peak areaNoxa knockdown
Reversed phase POSITIVE ION MODELEUCINE (CAS# 328-39-2); (M+NA)+98646Peak areaControl lentivirus
Reversed phase POSITIVE ION MODELEUCINE (CAS# 328-39-2); (M+NA)+104507Peak areaControl lentivirus
Reversed phase POSITIVE ION MODELEUCINE (CAS# 328-39-2); (M+NA)+105189Peak areaControl lentivirus

Return to search page
  logo